Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LIMK1 is a serine/threonine protein kinase that regulates actin cytoskeleton dynamics by phosphorylating and inactivating cofilin proteins. It plays a critical role in cell motility, cell cycle progression, neuronal development, and has been implicated in diseases such as Williams Syndrome and cancer, making it a potential therapeutic target.
Inhibition of LIMK1 kinase activity, leading to altered actin dynamics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LIM Domain Kinase 1 (LIMK1).